• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
20002021

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Review article

Search results

  • Crizotinib. ALK/Met inhibitor, oncolytic

    Nwizu, T., Kanteti, R., Kawada, I., Rolle, C., Vokes, E. E. & Salgia, R., 2011 Feb, In: Drugs of the Future. 36, 2, p. 91-98 8 p.

    Research output: Contribution to journalReview articlepeer-review

    7 Citations (Scopus)